Trials / Recruiting
RecruitingNCT07086794
Cocaine and Pentoxifylline (BED IN 47)
Targeting Immune Inflammation in Cocaine Use Disorder: A Human Laboratory Study With Pentoxifylline
- Status
- Recruiting
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- William Stoops · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This will be a human laboratory study evaluating the influence of pentoxifylline treatment on the effects of cocaine. Supported by and included in the Helping to End Addiction Long-term® (HEAL) Initiative.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | The effects of placebo will be determined. |
| DRUG | Cocaine (IV) | The effects of IV Cocaine will be determined. |
| DRUG | Pentoxifylline | The effects of pentoxifylline will be determined. |
Timeline
- Start date
- 2025-11-10
- Primary completion
- 2028-02-28
- Completion
- 2028-02-28
- First posted
- 2025-07-25
- Last updated
- 2025-11-18
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07086794. Inclusion in this directory is not an endorsement.